Pharmaceutical - Markets & Marketing, Analgesia

Filter

Popular Filters

Poor understanding is limiting innovation in pain drug development, says GBI Research

Poor understanding is limiting innovation in pain drug development, says GBI Research

10-03-2015

Limited understanding of pain pathophysiology continues to stand in the way of drug development, and…

AnalgesiaGBIGBI ResearchMarkets & MarketingPharmaceutical

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

Acute pain market to grow less than 0.5% between 2013 and 2023, says new research

24-10-2014

The acute pain market will experience only minimal growth between 2013 and 2023, according to biopharma…

AnalgesiaCelebrexDecision Resources GroupMarkets & MarketingPharmaceutical

Access and Norgine to partner on MuGard in European territories

Access and Norgine to partner on MuGard in European territories

07-08-2014

Emerging biopharma company Access Pharmaceuticals has entered into an exclusive license agreement with…

Access PharmaceuticalsAccess Pharmaceuticals, Inc.AnalgesiaEuropeMarkets & MarketingMucositisMuGardNorginePharmaceutical

Orexo’s Zubsolv could take market share from Suboxone, report suggests

Orexo’s Zubsolv could take market share from Suboxone, report suggests

30-10-2013

Edison Equity Research analysts say that expected new clinical data from Swedish drug developer Orexo…

AnalgesiaFinancialMarkets & MarketingNorth AmericaOrexo ABPharmaceuticalReckitt BenckiserZubsolv

Back to top